A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)

The goal of this trial is to measure what happens to 1 or 2 doses of MK-2828 in a person's body over time (pharmacokinetic or PK trial). Researchers want to learn if the PK of people with certain types of kidney disease is similar to the PK of healthy people.

NCT Number	NCT07348237
Lead Sponsor	Merck Sharp & Dohme LLC
Conditions	Chronic Kidney Failure, End-Stage Renal Disease, Renal Impairment
Enrollment	24 participants
Start Date	2026-03-02
Primary Completion	2026-09-21 (estimated)
Study Completion	2026-09-21 (estimated)
Updated on ClinicalTrials.gov	2026-08-14